Buy Cerebrolysin 215mg/5mL

▸The Clinical Neurotrophic Standard

Cerebrolysin is a standardized neuropeptide preparation derived from purified porcine brain proteins. Approximately 25% of the preparation consists of active neuropeptides, with the remainder being amino acids. It contains naturally-occurring neurotrophic factors including BDNF, NGF, CNTF, GDNF, and others in bioavailable form — creating a multi-target neurotrophic support that mimics the brain's own growth factor cocktail.

▸Clinical Evidence Base

Cerebrolysin has been studied in over 200 clinical trials and is approved as a pharmaceutical in over 40 countries for Alzheimer's disease, stroke rehabilitation, and traumatic brain injury. Meta-analyses have consistently demonstrated improvements in global cognitive function, activities of daily living, and neurological deficit scores following stroke. This robust clinical evidence distinguishes it from most research nootropics.

▸Mechanism: Multi-Factor Neuroprotection

The mixture acts through multiple neurotrophic receptors simultaneously — unlike single-peptide approaches, Cerebrolysin activates TrkA, TrkB, and GFRα receptors that regulate neuronal survival, synaptic plasticity, and neurogenesis. It also reduces amyloid precursor protein processing, decreases tau hyperphosphorylation, and protects against excitotoxicity — addressing multiple Alzheimer's pathology targets simultaneously.